BridgeMD
New treatment option for Ataxia, Gait
Official title Cerebellar Deep Brain Stimulation for the Treatment of Ataxia
ClinicalTrials.gov ID: NCT07427563
What this study is testing
- What it's testing
- Abnormal gait is often associated with immobility and falls, which in turn lead to loss of functional independence and death. While gait disorders may arise from many different etiologies, dysfunction of the cerebellum (a part of the brain with the function of coordination of movement) leading to gait disorders results in distinct features.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70
You may be able to join if
- Female or Male patients between age 20-70
- Diagnosis of primary ataxia (inclusive of congenital and hereditary subtypes without other neurological compromise)
- Head CT scan and cerebral MRI without any structural contraindications for safe DBS
- Patient able to give written consent
- Able to comply with all testing, follow-ups and study appointments and protocols
You likely can't join if
- Active neurologic disease including but not limited to epilepsy and certain brain tumors
- Secondary ataxia (such as due to stroke, medication, autoimmune disease, ischemia, tumor, or other lesion)
- Any contraindication to MRI scanning
- Likely to relocate or move during the study's one-year duration
- Presence of cardiac arrhythmias, or other cardiac, respiratory, renal or endocrine conditions that will result in significant risk from a surgical...
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.